Intelligence · Clinical Pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
- Programs
- 5,568
Quick answer
Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 401 programs
- United Therapeutics Europe 219 programs
- George Institute for 174 programs
- Takeda 163 programs
- AstraZeneca 145 programs
- HOFFMANN-LA ROCHE 145 programs
- MSD Merck Sharp 131 programs
- Anaxis Pharma 129 programs
- Regeneron UK 128 programs
- Telethon Foundation 113 programs
- Novartis India 112 programs
-
T, 260 mg/m2, paclitaxel for injection (albumin-bound)
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
TRT
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Thalidomide
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Tislelizumab combined with Lenvatinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Initially Unresectable Hepatocellular Carcinoma
1 trial -
Tumor Specific Antigen-loaded Dendritic Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tumor Gastric
1 trial -
Tumour Biopsy and Venous Blood Tests
United Therapeutics Europe Ltd
Soft Tissue Sarcoma
1 trial -
UE
The First People's Hospital of Lianyungang
Lung Cancer
1 trial -
Venclexta 100 MG Oral Tablet
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Whole Body Non-Contrast MRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Yishen Qutong Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial -
[68Ga]P3
The First People's Hospital of Lianyungang
Neoplasms
1 trial -
anti-thymocyte globulin
United Therapeutics Europe Ltd
Leukemia
1 trial -
blood sampling
Marker Therapeutics
Screening for Colon Cancer
1 trial -
blood sampling
Marker Therapeutics
Colorectal Cancer Screening
1 trial -
bpMRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
brachytherapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
chemotherapy plus TCM 1&ICIs plusTCM2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
chlorhexidine acetate gargle
Peking University Third Hospital
Esophageal Cancer
1 trial -
circulate free methylated EBV DNA
The First People's Hospital of Lianyungang
Extranodal Natural Killer/T-cell Lymphoma
1 trial -
circulating tumor cells test
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thyroid Nodule
1 trial -
conventional radiotherapy 74 Gy delivered in 37 fractions
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
erlotinib (Tarceva) and bexarotene (Targretin)
LIGAND PHARMACEUTICALS INC
Carcinoma, Non-small-cell Lung
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Testicular Germ Cell Tumor
1 trial -
goserelin acetate
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
irinotecan hydrochloride liposome injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Carcinoma
1 trial -
lidocaine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
2 trials -
live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
oral nutritional supplement
Hospital Authority, Hong Kong
Gastric Cancer
1 trial -
postoperative adjuvant chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Small-cell Lung Cancer
1 trial -
preoperative oral carbohydrate drink
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
progastrin
Grace Therapeutics
Colon Cancer Screening
1 trial -
radiochemotherapy 1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Non Small Cell Lung Cancer
1 trial -
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
standard-of-care imaging (18F-FDG, 68Ga-PSMA, or 68Ga-DOTATATE PET/CT), 68Ga-MY6349 PET/CT
The First People's Hospital of Lianyungang
Tumor
1 trial -
standard-of-care imaging (PSMA/FDG PET/CT), ACP3 PET/CT
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer (Diagnosis)
1 trial -
stereotactic body radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
stereotactic radiosurgery
United Therapeutics Europe Ltd
Head and Neck Cancer
1 trial -
substructure informed planning
United Therapeutics Europe Ltd
Brain Tumor
1 trial -
sunitinib or pazopanib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metastatic Renal Cell Carcinoma
1 trial -
the ginsenoside Rg3
The First People's Hospital of Lianyungang
Stage I Hepatocellular Carcinoma
1 trial -
therapeutic progesterone
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
white wine
United Therapeutics Europe Ltd
Unspecified Adult Solid Tumor, Protocol Specific
1 trial -
xDRIVE Tumor Profiling
The First People's Hospital of Lianyungang
Cancer
1 trial -
zanubrutinib 160 mg BID orally
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma
1 trial -
zanubrutinib, bendamustine, and obinutuzumab
The First People's Hospital of Lianyungang
Follicular Lymphoma
1 trial -
zoledronate therapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.
Data attribution: Data sources · All pipeline programs